These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6098453)

  • 21. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
    Levine MM; Young CR; Black RE; Takeda Y; Finkelstein RA
    J Clin Microbiol; 1985 Feb; 21(2):174-9. PubMed ID: 3882744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.
    Tamura S; Yamanaka A; Shimohara M; Tomita T; Komase K; Tsuda Y; Suzuki Y; Nagamine T; Kawahara K; Danbara H
    Vaccine; 1994 Apr; 12(5):419-26. PubMed ID: 8023550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches.
    Anosova NG; Chabot S; Shreedhar V; Borawski JA; Dickinson BL; Neutra MR
    Mucosal Immunol; 2008 Jan; 1(1):59-67. PubMed ID: 19079161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptides with antigenic specificity for bacterial toxins.
    Sela M; Arnon R; Jacob CO
    Ciba Found Symp; 1986; 119():184-99. PubMed ID: 2426052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunization with a synthetic peptide of cholera toxin B subunit. Obtention of neutralizing antibodies.
    Guyon-Gruaz A; Delmas A; Pedoussaut S; Halimi H; Milhaud G; Raulais D; Rivaille P
    Eur J Biochem; 1986 Sep; 159(3):525-8. PubMed ID: 3758076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation.
    Chang PP; Moss J; Twiddy EM; Holmes RK
    Infect Immun; 1987 Aug; 55(8):1854-8. PubMed ID: 3112012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.
    Wilson AD; Robinson A; Irons L; Stokes CR
    Vaccine; 1993; 11(2):113-8. PubMed ID: 8382416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-neutralization reactions of Escherichia coli and Vibrio cholerae enterotoxins as studied by rabbit skin inoculation test.
    Singh A; Mohan KS; Sethi SK; Vadehra DV
    Acta Microbiol Acad Sci Hung; 1977; 24(1):33-9. PubMed ID: 337760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.
    Guth BE; Twiddy EM; Trabulsi LR; Holmes RK
    Infect Immun; 1986 Nov; 54(2):529-36. PubMed ID: 2429930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal adaptation to cyclic AMP-mediated hypersecretion induced by the heat-labile enterotoxin of Vibrio cholerae and Escherichia coli.
    Lönnroth I; Hansson HA; Lange S
    Acta Pathol Microbiol Immunol Scand B; 1984 Feb; 92(1):53-60. PubMed ID: 6324533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes.
    Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT
    Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
    Huang J; Duan Q; Zhang W
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29802193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of type II heat-labile enterotoxin of Escherichia coli.
    Holmes RK; Twiddy EM; Pickett CL
    Infect Immun; 1986 Sep; 53(3):464-73. PubMed ID: 3017862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic and antigenic characteristics of Salmonella heat-labile enterotoxin.
    Kaura YK; Sharma VK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):386-404. PubMed ID: 3136609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Checkerboard immunoblotting recognizes twenty epitopes among the B subunit proteins of the cholera enterotoxin family.
    Qu ZH; Finkelstein RA
    Electrophoresis; 1993 Sep; 14(9):899-901. PubMed ID: 7693449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin.
    Dallas WS; Falkow S
    Nature; 1980 Dec; 288(5790):499-501. PubMed ID: 7003397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunostimulatory activity of LT-IIa, a type II heat-labile enterotoxin of Escherichia coli.
    Connell TD; Metzger D; Sfintescu C; Evans RT
    Immunol Lett; 1998 Jun; 62(2):117-20. PubMed ID: 9698108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of monoclonal antibodies to heat-labile enterotoxin encoded by a plasmid from a clinical isolate of Escherichia coli.
    Belisle BW; Twiddy EM; Holmes RK
    Infect Immun; 1984 Mar; 43(3):1027-32. PubMed ID: 6365779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.